Physician-Led Medical Weight Loss
A personalized program that combines medical evaluation, appropriate prescription options, nutrition guidance, movement planning, and ongoing follow-up to support meaningful, sustainable progress.
Medication is prescribed only after an individualized medical evaluation and when clinically appropriate.
Weight Management Is More Than a Number on the Scale
Weight is influenced by appetite signaling, metabolic health, sleep, stress, medications, hormones, movement, nutrition, genetics, and life circumstances.
PrimeCell begins with a medical consultation rather than a one-size-fits-all prescription. We review your health history, current medications, prior weight-loss efforts, goals, and potential risk factors before discussing the options that may fit your needs.
How GLP-1-Based Medications May Support Weight Loss
GLP-1 is a hormone involved in appetite and blood-sugar regulation. Some medications mimic GLP-1 signaling; tirzepatide acts on both GIP and GLP-1 pathways. Effects vary by medication and by person.
Brain
May reduce hunger, quiet persistent food thoughts, and help you feel satisfied with less food.
Stomach
Can slow gastric emptying, which may extend the feeling of fullness after meals.
Pancreas
Supports glucose-dependent insulin signaling and may reduce inappropriate glucagon release.
Daily Habits
Reduced appetite can create an opportunity to build sustainable nutrition, movement, and strength habits.
These medications do not replace nutritious eating, physical activity, sleep, or ongoing medical care.
Built Around Your Health, Goals, and Response
Potential Prescription Options
The appropriate choice depends on medical history, eligibility, availability, cost, potential risks, treatment goals, and individual response.
Semaglutide-Based Therapy
Semaglutide is a GLP-1 receptor agonist. FDA-approved products have different indications and brand names depending on whether they are used for chronic weight management or type 2 diabetes.
- Typically administered once weekly when prescribed as an injection
- Dose is generally increased gradually to improve tolerability
- May reduce appetite and increase fullness
Tirzepatide-Based Therapy
Tirzepatide acts on both GIP and GLP-1 receptors. FDA-approved products have distinct indications for chronic weight management and type 2 diabetes.
- Typically administered once weekly
- Dose is generally titrated according to tolerance and response
- May influence appetite, fullness, and glucose regulation
PrimeCell will discuss whether an FDA-approved medication, another treatment approach, or no medication is the most appropriate option. Product sourcing, regulatory status, dosing, potential benefits, risks, and alternatives should be reviewed before treatment.
Learn More About GLP-1 Therapy and Long-Term Weight Management
These third-party educational videos are included for general information and do not replace a consultation with your medical professional.
How GLP-1 Medications Work and What Patients Should Know
An evidence-based discussion covering mechanisms, potential side effects, long-term considerations, and medication access.
Why Medication Works Best as Part of a Complete Plan
A concise explanation of why nutrition, movement, and sustainable habits remain essential during and after treatment.
Your Weight-Loss Journey at PrimeCell
Comprehensive Evaluation
Discuss your health history, weight trajectory, symptoms, goals, medications, and prior approaches. Laboratory testing may be recommended when clinically indicated.
Personalized Plan
Review medication and non-medication options, expected responsibilities, risks, alternatives, nutrition priorities, and an initial movement strategy.
Careful Titration
When medication is prescribed, dosing is adjusted gradually according to the treatment plan, tolerance, safety, and response.
Ongoing Support
Follow-up visits focus on progress, side effects, strength and nutrition, barriers, and the strategy for long-term maintenance.
Is Medical Weight Management Right for You?
A consultation may be appropriate for adults with obesity or overweight plus weight-related health concerns who have not achieved or maintained adequate improvement with lifestyle measures alone.
Eligibility is individualized. BMI is one consideration, but it is not the only factor. Your clinician will also consider health conditions, medication history, body composition, prior treatment, risks, and goals.
Important Screening Considerations
GLP-1-based treatment may not be appropriate during pregnancy or while trying to become pregnant. Additional caution or avoidance may be needed with certain personal or family histories, including medullary thyroid carcinoma or MEN 2, and with selected gastrointestinal, pancreatic, gallbladder, kidney, or eating-disorder concerns.
Provide a complete medication, supplement, and medical history so risks and interactions can be reviewed carefully.
Potential Side Effects and When to Seek Care
Side effects vary by medication, dose, medical history, hydration, eating pattern, and individual response.
Commonly Reported
Nausea, constipation, diarrhea, vomiting, abdominal discomfort, reflux, reduced appetite, fatigue, headache, or injection-site symptoms may occur.
Nutrition and Muscle
Very low intake, dehydration, inadequate protein, and loss of lean tissue are concerns that deserve proactive nutrition and resistance-training strategies.
Seek Prompt Medical Advice
Severe or persistent abdominal pain, repeated vomiting, inability to maintain hydration, symptoms of an allergic reaction, severe weakness, or other rapidly worsening symptoms require prompt medical attention.
Meet Dr. Kenny Chantasi
Dr. Chantasi is board certified in Physical Medicine and Rehabilitation and Pain Medicine.
His approach considers function, mobility, pain, medical history, and sustainable lifestyle change alongside weight-management treatment. The goal is to create a plan that helps you feel informed, supported, and confident about each decision.
Medical Weight Loss and GLP-1 Therapy
How much weight will I lose?
There is no guaranteed amount. Results depend on the medication, dose, duration, starting health, nutrition, activity, sleep, adherence, side effects, and individual biology. Your plan should be evaluated by changes in health, function, body composition, and sustainability—not only scale weight.
How quickly should I expect changes?
Appetite changes may occur earlier than visible weight changes. Meaningful weight loss usually develops gradually over months. Dose increases should not be rushed solely to accelerate results.
Will I need to stay on medication forever?
Obesity is often a chronic condition, and some people benefit from long-term therapy. The duration should be decided with your clinician based on benefits, side effects, risk, preferences, access, and the maintenance plan. Weight regain can occur after discontinuation.
Are semaglutide and tirzepatide the same?
No. Semaglutide acts on the GLP-1 receptor, while tirzepatide acts on both GIP and GLP-1 receptors. They have different FDA-approved products, indications, dosing schedules, labeling, and clinical considerations.
Can I receive treatment through telemedicine?
Telemedicine may be available for eligible Florida patients, although an in-person examination, laboratory testing, or other evaluation may be required depending on your history and the proposed treatment.
Does medication replace diet and exercise?
No. Medication may reduce hunger and help support behavior change, but nutrition quality, adequate protein and hydration, physical activity, strength training, sleep, and follow-up remain central to healthy weight management.
What is the difference between FDA-approved and compounded medication?
FDA-approved medications have undergone FDA review for specific indications, manufacturing, quality, safety, and effectiveness. Compounded medications are not FDA approved. When compounding is discussed, the reason, source, regulatory status, limitations, dosing risks, and alternatives should be reviewed carefully.
Is treatment covered by insurance?
Coverage varies widely by plan, diagnosis, medication, prior-authorization requirements, and pharmacy benefits. PrimeCell can explain its program fees, but patients should confirm medication coverage directly with their insurer or pharmacy-benefit manager.
A More Personal Path Toward Better Health
Schedule a consultation to review your goals, medical history, prior efforts, medication eligibility, and the program options available through PrimeCell.
Important Medical and Medication Notice
This page is for general educational purposes and does not establish a physician-patient relationship or replace individualized medical advice. Prescription weight-management medication is not appropriate for everyone. Medication selection, dosing, product source, regulatory status, potential benefits, risks, alternatives, monitoring requirements, and financial responsibility must be reviewed during a medical consultation. FDA-approved products have specific indications and labeling. Compounded medications are not FDA approved. No representation or guarantee is made regarding individual outcomes.
Patient education sources: NIDDK · FDA guidance on unapproved GLP-1 products · World Health Organization